跳至主要内容
临床试验/CTRI/2019/03/018307
CTRI/2019/03/018307招募中未知

To study the efficacy and safety of Sodium Glucose Co-Transporters Type 2 (SGLT2) inhibitors for the treatment of Type 2 Diabetes Mellitus

Jawaharlal Nehru Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients having age 18 years and above with type 2 DM on SGLT2 inhibitors and/ or
  • on other oral antidiabetics

排除标准

  • Type 1 Diabetes Mellitus
  • Patients on insulin or other injectable agents
  • Patients on systemic corticosteroids and other drugs which may affect the glycaemic
  • History of Diabetic Ketoacidosis (DKA)
  • Significant Diabetic nephropathy
  • Patients with significant liver disease
  • Congestive Heart Failure (CHF)
  • Patients with significant lung disease
  • Septicaemia
  • Psychotic patient
  • Known cases of HIV / HBsAg / Anti-HCV and immunocompromised patients
  • Any other severe systemic illness

研究者

相似试验